Drug Shortage Report for ZOVIRAX
Report ID | 161040 |
Drug Identification Number | 00886157 |
Brand name | ZOVIRAX |
Common or Proper name | Acyclovir Oral Suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | ACYCLOVIR |
Strength(s) | 200MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 475ML |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2022-05-17 |
Estimated end date | 2022-08-17 |
Actual end date | 2022-08-17 |
Shortage status | Resolved |
Updated date | 2022-08-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-08-18 | English | Compare |
v8 | 2022-08-17 | French | Compare |
v7 | 2022-08-17 | English | Compare |
v6 | 2022-07-27 | French | Compare |
v5 | 2022-07-27 | English | Compare |
v4 | 2022-06-29 | French | Compare |
v3 | 2022-06-29 | English | Compare |
v2 | 2022-05-20 | French | Compare |
v1 | 2022-05-20 | English | Compare |
Showing 1 to 9 of 9